Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Limerick BioPharma
company
About
Limerick BioPharma develops compounds which can be used adjunctively with marketed and investigational drugs.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Developer Platform,Pharmaceutical
- Founded date
- Jan 1, 2004
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Limerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients' lives. Their compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug's desired effects. In the monotherapy setting, they are developing novel compounds that target the treatment of metabolic diseases such as hypercholesteremia and hyperglycemia.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$35.20M
Limerick BioPharma has raised a total of
$35.20M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2009 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2009 | Series C | $15M | 1 | — | — | Detail |
| Jun 11, 2008 | Series Unknown | $15.20M | 1 | — | — | Detail |
| Sep 17, 2007 | Debt Financing | $5M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Limerick BioPharma is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
